ZFAS1 and cholangiocarcinoma: In conclusion, the results presented that overexpressed ZFAS1 is associated with dismal prognosis for cholangiocarcinoma patients and this aberrant modulates proliferation and metastasis via miR‐296‐5p/USF1, which might activate oncogenes expression.